Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: A case-control study

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Sgourakis, George ^a,b   Gockel, Ines ^a   Karaliotas, Constantine ^b   Moehler, Markus ^a   Schimanski, Carl C ^a   Schmidberger, Heinz ^a   Junginger, Theodor ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CHEMORADIOTHERAPY; COMORBIDITY; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PERITONEAL DISEASE; SELF EXPANDING METAL STENT; SQUAMOUS CELL CARCINOMA; STENT; TUMOR LOCALIZATION; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARCINOMA; CASE-CONTROL STUDIES; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS;

EID: 84857024667     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-70     Document Type: Article

References (15)

1. Tytgat GN, Bartelink H, Bernards R, et al. Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus 2004, 17:10-26. 10.1111/j.1442-2050.2004.00371.x, 15209736.
2. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study. Ned Tijdschr Geneeskd 2005, 149:2800-2806.
3. Shenfine J, McNamee P, Steen N, et al. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005, 9:1-121.
4. Bergquist H, Wenger U, Johnsson E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005, 18:131-139. 10.1111/j.1442-2050.2005.00467.x, 16045572.
5. Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001, 54:549-557. 10.1067/mge.2001.118947, 11677469.
6. Sgourakis G, Gockel I, Radtke A, et al. The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes. Dig Dis Sci 2010, 55:3018-3030. 10.1007/s10620-010-1250-1, 20440646.
7. Gockel I, Kneist W, Junginger T. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J Surg 2006, 30:183-190. 10.1007/s00268-005-7861-6, 16425075.
8. Kneist W, Schreckenberger M, Bartenstein P, et al. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 2004, 139:1043-1049. 10.1001/archsurg.139.10.1043, 15492140.
9. Siewert JR, Holscher AH, Becker K, Gossner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 1987, 58:25-32.
10. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-1598. 10.1056/NEJM199206113262403, 1584260.
11. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 1995, 76:178-186. 10.1002/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO;2-D, 8625089.
12. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999, 281:1623-1627. 10.1001/jama.281.17.1623, 10235156.
13. Slabber CF, Nel JS, Schoeman L, et al. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998, 21:462-465. 10.1097/00000421-199810000-00008, 9781600.
14. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2006, 1:CD002092.
15. Conroy T, Etienne PL, Adenis A, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. European organisation for research and treatment of cancer gastrointestinal tract cancer cooperative group. Ann Oncol 2002, 13:721-729. 10.1093/annonc/mdf063, 12075740.